Key statistics
As of last trade, Oncolytics Biotech Inc (ONCY:NAQ) traded at 0.94, 11.89% above the 52 week low of 0.8401 set on Oct 01, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.9801 |
---|---|
High | 0.9999 |
Low | 0.9374 |
Bid | 0.9325 |
Offer | 0.9423 |
Previous close | 0.98 |
Average volume | 399.60k |
---|---|
Shares outstanding | 77.04m |
Free float | 74.10m |
P/E (TTM) | -- |
Market cap | 75.55m USD |
EPS (TTM) | -0.2608 USD |
Data delayed at least 15 minutes, as of Nov 22 2024 19:21 GMT.
More ▼
- Oncolytics Biotech® Reports Third Quarter 2024 Financial Results and Operational Highlights
- Oncolytics Biotech® to Host Conference Call to Discuss Third Quarter Financial Results and Recent Operational Highlights
- Oncolytics Biotech® Announces Key Progress and Upcoming Studies for Breast and Pancreatic Cancer Treatments, Prepares for FDA Accelerated Approval Path
- Oncolytics Biotech® Reports Favorable Results for BRACELET-1 Breast Cancer Study Reinforcing Path to Funding of a Registration-Enabling Study
- Oncolytics Biotech® to Participate in Fireside Chats at Two Investment Conferences in September
More ▼